Chemoinformaics analysis of 6-hydroxygenistein
Molecular Weight | 286.239 | nRot | 1 |
Heavy Atom Molecular Weight | 276.159 | nRig | 18 |
Exact Molecular Weight | 286.048 | nRing | 3 |
Solubility: LogS | -3.326 | nHRing | 1 |
Solubility: LogP | 1.944 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 36.5299 |
nHD | 4 | BPOL | 12.6361 |
QED | 0.511 |
Synth | 2.451 |
Natural Product Likeliness | 1.444 |
NR-PPAR-gamma | 0.965 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.126 |
HIA | 0.017 |
CACO-2 | -5.116 |
MDCK | 0.00000632 |
BBB | 0.008 |
PPB | 0.984153 |
VDSS | 0.467 |
FU | 0.0421746 |
CYP1A2-inh | 0.935 |
CYP1A2-sub | 0.11 |
CYP2c19-inh | 0.109 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.654 |
CYP2c9-sub | 0.654 |
CYP2d6-inh | 0.684 |
CYP2d6-sub | 0.272 |
CYP3a4-inh | 0.202 |
CYP3a4-sub | 0.071 |
CL | 6.717 |
T12 | 0.921 |
hERG | 0.053 |
Ames | 0.243 |
ROA | 0.402 |
SkinSen | 0.947 |
Carcinogencity | 0.345 |
EI | 0.939 |
Respiratory | 0.052 |
NR-Aromatase | 0.434 |
Antiviral | Yes |
Prediction | 0.725537 |